
Combined treatment of the immunoconjugate bivatuzumab mertansine and fractionated irradiation improves local tumour control in vivo
Keywords: درمان ترکیبی; Combined treatment; Molecular targeting; Antibody; Fractionated irradiation; Local tumour control; CD44v6; Bivatuzumab mertansine;